A 10-year comparative analysis of medical and surgical specialty lobbying by physician professional organizations
Max Bouvette, Stephanie Beveridge, Kirtana Kumar, Mehak Ali, Justin Dvorak, Nirmal Choradia, Ryan Nipp

TL;DR
This study analyzed 10 years of lobbying spending by physician organizations and found a significant decline in their investments, especially when adjusted for inflation.
Contribution
The paper provides the first 10-year comparative analysis of lobbying trends by medical and surgical specialty organizations in the U.S.
Findings
Median annual lobbying spending by PPOs was $71 million, with a significant downward trend over the study period.
Medical PPOs spent the most (45% of total), followed by overlapping PPOs (39%), and surgical PPOs (16%).
The median lobbying spending per physician was $78 annually.
Abstract
Physician professional organizations (PPOs) engage in lobbying to advocate for their interests and influence health policy. However, trends in lobbying across specialties are not well characterized. Disproportionate spending across PPOs may affect the ability to shape healthcare legislation and ensure that all physician voices are represented. We analyzed publicly available lobbying data from OpenSecrets.org covering 2014-2023, adjusted to 2023 USD. A total of 109 PPOs were included. Physician professional organizations were categorized as medical (n = 68), surgical (n = 29), or overlapping (n = 12), based on whether they primarily represented medical specialties, surgical specialties, or both. Physician workforce data from the AAMC were used to calculate spending per-physician. Temporal trends were assessed using a Mann-Kendall test. Median annual PPO lobbying spending was $71…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHealthcare Policy and Management · Pharmaceutical industry and healthcare · Economic and Financial Impacts of Cancer
